Literature DB >> 3804026

Relationship of HLA protein display to activation of 2-5A synthetase in HBe antigen or anti-HBe positive chronic HBV infection.

T Ikeda, M Pignatelli, A M Lever, H C Thomas.   

Abstract

In this study we have examined the density of HLA class I protein display on the hepatocytes of patients with HBe antigen (HBeAg) or anti-HBe (HBeAb) positive chronic hepatitis B virus (HBV) infection and related this to the level of interferon activation of these cells determined by measuring hepatic oligo 2-5A synthetase activity. In HBeAg positive patients the density of HLA class I (HLA-I) protein was not significantly increased above that found in uninfected liver, but levels of 2-5A synthetase were twice normal. In anti-HBe positive patients, HLA-I density was markedly increased in the presence of normal 2-5A synthetase activity. These data are consistent with type I (alpha or beta) interferon activation of the hepatocytes in HBeAg positive patients and type II (gamma) interferon activity in anti-HBe positive subjects.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3804026      PMCID: PMC1433958          DOI: 10.1136/gut.27.12.1498

Source DB:  PubMed          Journal:  Gut        ISSN: 0017-5749            Impact factor:   23.059


  16 in total

1.  HLA class I antigens on the hepatocyte membrane during recovery from acute hepatitis B virus infection and during interferon therapy in chronic hepatitis B virus infection.

Authors:  M Pignatelli; J Waters; D Brown; A Lever; S Iwarson; Z Schaff; R Gerety; H C Thomas
Journal:  Hepatology       Date:  1986 May-Jun       Impact factor: 17.425

Review 2.  The interferons and their inducers: molecular and therapeutic considerations. 1.

Authors:  S E Grossberg
Journal:  N Engl J Med       Date:  1972-07-06       Impact factor: 91.245

Review 3.  Biochemistry of interferons and their actions.

Authors:  P Lengyel
Journal:  Annu Rev Biochem       Date:  1982       Impact factor: 23.643

4.  Evidence that types I and II interferons have different receptors.

Authors:  A A Branca; C Baglioni
Journal:  Nature       Date:  1981-12-24       Impact factor: 49.962

5.  Clinical and histological events preceding hepatitis B e antigen seroconversion in chronic type B hepatitis.

Authors:  Y F Liaw; C M Chu; I J Su; M J Huang; D Y Lin; C S Chang-Chien
Journal:  Gastroenterology       Date:  1983-02       Impact factor: 22.682

6.  Hepatitis B virus and HLA antigen display in the liver during chronic hepatitis B virus infection.

Authors:  L Montano; G C Miescher; A H Goodall; K H Wiedmann; G Janossy; H C Thomas
Journal:  Hepatology       Date:  1982 Sep-Oct       Impact factor: 17.425

7.  Effects of prednisolone/azathioprine in chronic hepatitis B viral infection.

Authors:  I V Weller; M F Bassendine; A K Murray; A Craxi; H C Thomas; S Sherlock
Journal:  Gut       Date:  1982-08       Impact factor: 23.059

8.  Studies with pure mouse Ehrlich ascites tumor interferons alpha and beta: patterns of induction of (2'-5') (A)n synthetase and of a double-stranded RNA-dependent protein kinase in mouse cells and human cells.

Authors:  R J Broeze; J P Dougherty; J Pichon; B M Jayaram; P Lengyel
Journal:  J Interferon Res       Date:  1981-02

9.  Variation of (2'-5') oligo A synthetase level in lymphocytes and granulocytes of patients with viral infections and leukemia.

Authors:  A Schattner; D Wallach; G Merlin; T Hahn; S Levin; B Ramot; M Revel
Journal:  J Interferon Res       Date:  1982

10.  Interferon-Like Virus-Inhibitor Induced in Human Leukocytes by Phytohemagglutinin.

Authors:  E F Wheelock
Journal:  Science       Date:  1965-07-16       Impact factor: 47.728

View more
  7 in total

1.  Alpha-interferon enhances gamma-interferon production of peripheral blood mononuclear cells pre-activated with phytohemagglutinin.

Authors:  K Katayama; N Hayashi; T Takehara; K Suzuki; A Kasahara; H Fusamoto; T Kamada
Journal:  Gastroenterol Jpn       Date:  1993-10

Review 2.  Interferon in the management of chronic hepatitis B.

Authors:  R P Perrillo
Journal:  Dig Dis Sci       Date:  1993-04       Impact factor: 3.199

3.  Effects of cytokines on HLA class I antigen expression on Huh6 and HB611 cells.

Authors:  T Towata; N Hayashi; K Katayama; T Takehara; E Miyoshi; Y Kawanishi; K Ueda; A Kasahara; H Fusamoto; T Kamada
Journal:  Gastroenterol Jpn       Date:  1993-04

4.  Class I and class II major histocompatibility complex antigens on hepatocytes: importance of the method of detection and expression in histologically normal and diseased livers.

Authors:  G Senaldi; A Lobo-Yeo; A P Mowat; G Mieli-Vergani; D Vergani
Journal:  J Clin Pathol       Date:  1991-02       Impact factor: 3.411

5.  Effects of alpha-interferon on gamma-interferon production of peripheral blood mononuclear cells in hepatitis B virus carriers.

Authors:  K Katayama; N Hayashi; T Takehara; T Towata; A Kasahara; H Fusamoto; T Kamada
Journal:  J Clin Immunol       Date:  1992-09       Impact factor: 8.317

6.  Effect of recombinant interleukin 2 on hepatitis B e antigen positive chronic hepatitis.

Authors:  M Onji; H Kondoh; N Horiike; S Yamaguchi; Y Ogawa; I Kumon; Y Ohta
Journal:  Gut       Date:  1987-12       Impact factor: 23.059

Review 7.  Liver lesions in hepatitis B viral infection.

Authors:  V J Desmet
Journal:  Yale J Biol Med       Date:  1988 Jan-Feb
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.